Skip to Content

Emverm Approval History

FDA Approved: Yes (First approved January 15, 2016)
Brand name: Emverm
Generic name: mebendazole
Dosage form: Chewable Tablets
Company: Impax Laboratories, Inc.
Treatment for: Pinworm Infection (Enterobius vermicularis), Whipworm Infection, Hookworm Infection (Necator or Ancylostoma), Ascariasis

Emverm (mebendazole) is a chewable tablet formulation of the approved anthelmintic mebendazole for the treatment of Enterobius vermicularis (pinworm), Trichuris trichiura (whipworm), Ascaris lumbricoides (common roundworm), Ancylostoma duodenale (common hookworm), Necator americanus (American hookworm) in single or mixed infections.

Development History and FDA Approval Process for Emverm

DateArticle
Jan 18, 2016Approval Impax Receives Approval of Emverm (mebendazole) Chewable Tablets

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide